Flavopiridol in Treating Patients With Unresectable or Metastatic Kidney Cancer

Sponsor
Southwest Oncology Group (Other)
Overall Status
Completed
CT.gov ID
NCT00016939
Collaborator
National Cancer Institute (NCI) (NIH)
101
59

Study Details

Study Description

Brief Summary

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

PURPOSE: Phase II trial to study the effectiveness of flavopiridol in treating patients who have unresectable or metastatic kidney cancer.

Condition or Disease Intervention/Treatment Phase
Phase 2

Detailed Description

OBJECTIVES:
  • Determine the confirmed and unconfirmed complete and partial responses in patients with unresectable or metastatic renal cell cancer treated with flavopiridol.

  • Determine the 6-month time to treatment failure rate and overall survival rate of patients treated with this drug.

  • Determine the qualitative and quantitative toxic effects of this drug in this patient population.

  • Determine, in a preliminary manner, the association of tumor response with pretreatment tumor proliferative and apoptotic rates in patients treated with this drug.

OUTLINE: This is a multicenter study.

Patients receive flavopiridol IV over 1 hour on days 1-3. Treatment repeats every 21 days in the absence of disease progression or unacceptable toxicity.

Patients are followed every 3 months for 1 year and then every 6 months for 2 years.

PROJECTED ACCRUAL: A total of 20-35 patients will be accrued for this study.

Study Design

Study Type:
Interventional
Primary Purpose:
Treatment
Official Title:
A Phase II Study of Flavopiridol 1 Hour Bolus Days 1-3 Q 21 Days in Patients With Advanced Renal Cell Cancer
Study Start Date :
May 1, 2001
Actual Study Completion Date :
Apr 1, 2006

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    N/A and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    DISEASE CHARACTERISTICS:
    • Histologically or cytologically confirmed unresectable primary (M0) or metastatic renal cell cancer

    • At least 1 unidimensionally measurable lesion

    • At least 20 mm by conventional techniques OR

    • At least 10 mm by spiral CT scan

    • Soft tissue disease that has been previously irradiated within the past 2 months is not considered measurable

    • Soft tissue disease within a previously irradiated field is considered measurable provided disease has progressed and other measurable disease exists outside of the radiation field

    • No prior or concurrent brain metastases

    PATIENT CHARACTERISTICS:
    Age:
    • Not specified
    Performance status:
    • Zubrod 0-2
    Life expectancy:
    • Not specified
    Hematopoietic:
    • No hypercoagulable state other than renal cell cancer
    Hepatic:
    • Not specified
    Renal:
    • Not specified
    Cardiovascular:
    • No symptomatic congestive heart failure

    • No unstable angina pectoris

    • No cardiac arrhythmia

    • No prior isolated occurrence of deep venous thrombosis within the past 6 months

    Pulmonary:
    • No prior isolated occurrence of pulmonary embolism within the past 6 months
    Other:
    • No other malignancy within the past 5 years except adequately treated basal cell or squamous cell skin cancer, carcinoma in situ of the cervix, or stage I or II cancer in complete remission

    • No history of allergic reactions to compounds of similar chemical or biologic composition to flavopiridol (e.g., staurosporine, deschloroflavopiridol, or butyrolactone I)

    • No other uncontrolled illness (e.g., diabetes mellitus)

    • No ongoing or active infection

    • No psychiatric illness or social situation that would preclude study compliance

    • Not pregnant or nursing

    • Negative pregnancy test

    • Fertile patients must use effective contraception

    PRIOR CONCURRENT THERAPY:
    Biologic therapy:
    • 1 prior immunotherapy regimen comprising interferon and/or interleukin-2 allowed

    • At least 28 days since prior immunotherapy and recovered

    • No concurrent prophylactic filgrastim (G-CSF)

    Chemotherapy:
    • No prior chemotherapy for renal cell cancer
    Endocrine therapy:
    • Not specified
    Radiotherapy:
    • See Disease Characteristics

    • At least 21 days since prior radiotherapy and recovered

    Surgery:
    • See Disease Characteristics

    • Prior resection of primary tumor allowed

    • At least 28 days since prior surgery and recovered

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 University of Alabama at Birmingham Comprehensive Cancer Center Birmingham Alabama United States 35294-3300
    2 MBCCOP - Gulf Coast Mobile Alabama United States 36688
    3 CCOP - Greater Phoenix Phoenix Arizona United States 85006-2726
    4 Veterans Affairs Medical Center - Phoenix (Hayden) Phoenix Arizona United States 85012
    5 Veterans Affairs Medical Center - Tucson Tucson Arizona United States 85723
    6 Arizona Cancer Center Tucson Arizona United States 85724
    7 University of Arkansas for Medical Sciences Little Rock Arkansas United States 72205
    8 Veterans Affairs Medical Center - Little Rock (McClellan) Little Rock Arkansas United States 72205
    9 Cancer Center and Beckman Research Institute, City of Hope Duarte California United States 91010-3000
    10 USC/Norris Comprehensive Cancer Center and Hospital Los Angeles California United States 90033-0804
    11 Veterans Affairs Medical Center - West Los Angeles Los Angeles California United States 90073
    12 Jonsson Comprehensive Cancer Center, UCLA Los Angeles California United States 90095-1781
    13 Veterans Affairs Outpatient Clinic - Martinez Martinez California United States 94553
    14 CCOP - Bay Area Tumor Institute Oakland California United States 94609-3305
    15 Chao Family Comprehensive Cancer Center Orange California United States 92868
    16 University of California Davis Cancer Center Sacramento California United States 95817
    17 University of California Davis Medical Center Sacramento California United States 95817
    18 Veterans Affairs Medical Center - San Francisco San Francisco California United States 94121
    19 UCSF Cancer Center and Cancer Research Institute San Francisco California United States 94143-0128
    20 CCOP - Santa Rosa Memorial Hospital Santa Rosa California United States 95403
    21 David Grant Medical Center Travis Air Force Base California United States 94535
    22 University of Colorado Cancer Center Denver Colorado United States 80010
    23 Veterans Affairs Medical Center - Denver Denver Colorado United States 80220
    24 CCOP - Atlanta Regional Atlanta Georgia United States 30342-1701
    25 Dwight David Eisenhower Army Medical Center Fort Gordon Georgia United States 30905-5650
    26 Cancer Research Center of Hawaii Honolulu Hawaii United States 96813
    27 MBCCOP - University of Illinois at Chicago Chicago Illinois United States 60612-7323
    28 Veterans Affairs Medical Center - Chicago (Westside Hospital) Chicago Illinois United States 60612
    29 CCOP - Central Illinois Decatur Illinois United States 62526
    30 Veterans Affairs Medical Center - Hines (Hines Junior VA Hospital) Hines Illinois United States 60141
    31 Loyola University Medical Center Maywood Illinois United States 60153
    32 University of Kansas Medical Center Kansas City Kansas United States 66160-7357
    33 CCOP - Wichita Wichita Kansas United States 67214-3882
    34 Veterans Affairs Medical Center - Wichita Wichita Kansas United States 67218
    35 Veterans Affairs Medical Center - Lexington Lexington Kentucky United States 40511-1093
    36 Albert B. Chandler Medical Center, University of Kentucky Lexington Kentucky United States 40536-0084
    37 MBCCOP - LSU Health Sciences Center New Orleans Louisiana United States 70112
    38 Tulane University School of Medicine New Orleans Louisiana United States 70112
    39 Veterans Affairs Medical Center - New Orleans New Orleans Louisiana United States 70112
    40 Louisiana State University Health Sciences Center - Shreveport Shreveport Louisiana United States 71130-3932
    41 Veterans Affairs Medical Center - Shreveport Shreveport Louisiana United States 71130
    42 Boston Medical Center Boston Massachusetts United States 02118
    43 Veterans Affairs Medical Center - Boston (Jamaica Plain) Jamaica Plain Massachusetts United States 02130
    44 Veterans Affairs Medical Center - Ann Arbor Ann Arbor Michigan United States 48105
    45 CCOP - Ann Arbor Regional Ann Arbor Michigan United States 48106
    46 University of Michigan Comprehensive Cancer Center Ann Arbor Michigan United States 48109-0752
    47 Barbara Ann Karmanos Cancer Institute Detroit Michigan United States 48201-1379
    48 Veterans Affairs Medical Center - Detroit Detroit Michigan United States 48201-1932
    49 Henry Ford Hospital Detroit Michigan United States 48202
    50 CCOP - Grand Rapids Clinical Oncology Program Grand Rapids Michigan United States 49503
    51 Providence Hospital - Southfield Southfield Michigan United States 48075-9975
    52 CCOP - Duluth Duluth Minnesota United States 55805
    53 Veterans Affairs Medical Center - Biloxi Biloxi Mississippi United States 39531-2410
    54 University of Mississippi Medical Center Jackson Mississippi United States 39216-4505
    55 Veterans Affairs Medical Center - Jackson Jackson Mississippi United States 39216
    56 Keesler Medical Center - Keesler AFB Keesler AFB Mississippi United States 39534-2576
    57 Veterans Affairs Medical Center - Kansas City Kansas City Missouri United States 64128
    58 CCOP - Kansas City Kansas City Missouri United States 64131
    59 St. Louis University Health Sciences Center Saint Louis Missouri United States 63110-0250
    60 CCOP - St. Louis-Cape Girardeau Saint Louis Missouri United States 63141
    61 CCOP - Cancer Research for the Ozarks Springfield Missouri United States 65807
    62 CCOP - Montana Cancer Consortium Billings Montana United States 59101
    63 Veterans Affairs Medical Center - Albuquerque Albuquerque New Mexico United States 87108-5138
    64 MBCCOP - University of New Mexico HSC Albuquerque New Mexico United States 87131
    65 Veterans Affairs Medical Center - Albany Albany New York United States 12208
    66 Herbert Irving Comprehensive Cancer Center New York New York United States 10032
    67 University of Rochester Medical Center Rochester New York United States 14642
    68 CCOP - Southeast Cancer Control Consortium Winston-Salem North Carolina United States 27104-4241
    69 Veterans Affairs Medical Center - Cincinnati Cincinnati Ohio United States 45220-2288
    70 Barrett Cancer Center, The University Hospital Cincinnati Ohio United States 45267-0502
    71 Cleveland Clinic Taussig Cancer Center Cleveland Ohio United States 44195
    72 CCOP - Columbus Columbus Ohio United States 43206
    73 Veterans Affairs Medical Center - Dayton Dayton Ohio United States 45428
    74 CCOP - Dayton Kettering Ohio United States 45429
    75 CCOP - Toledo Community Hospital Oncology Program Toledo Ohio United States 43623-3456
    76 Oklahoma Medical Research Foundation Oklahoma City Oklahoma United States 73104
    77 Veterans Affairs Medical Center - Oklahoma City Oklahoma City Oklahoma United States 73104
    78 Oregon Cancer Center Portland Oregon United States 97201-3098
    79 Veterans Affairs Medical Center - Portland Portland Oregon United States 97207
    80 CCOP - Columbia River Program Portland Oregon United States 97213
    81 Veterans Affairs Medical Center - Charleston Charleston South Carolina United States 29401-5799
    82 Medical University of South Carolina Charleston South Carolina United States 29425-0721
    83 CCOP - Greenville Greenville South Carolina United States 29615
    84 CCOP - Upstate Carolina Spartanburg South Carolina United States 29303
    85 Brooke Army Medical Center Fort Sam Houston Texas United States 78234
    86 University of Texas Medical Branch Galveston Texas United States 77555-0209
    87 Baylor College of Medicine Houston Texas United States 77030
    88 Veterans Affairs Medical Center - Houston Houston Texas United States 77030
    89 Texas Tech University Health Science Center Lubbock Texas United States 79415
    90 University of Texas Health Science Center at San Antonio San Antonio Texas United States 78284-7811
    91 Veterans Affairs Medical Center - San Antonio (Murphy) San Antonio Texas United States 78284
    92 Veterans Affairs Medical Center - Temple Temple Texas United States 76504
    93 CCOP - Scott and White Hospital Temple Texas United States 76508
    94 Huntsman Cancer Institute Salt Lake City Utah United States 84112
    95 Veterans Affairs Medical Center - Salt Lake City Salt Lake City Utah United States 84148
    96 Eastern Virginia Medical School Norfolk Virginia United States 23507
    97 CCOP - Virginia Mason Research Center Seattle Washington United States 98101
    98 Swedish Cancer Institute Seattle Washington United States 98104
    99 Veterans Affairs Medical Center - Seattle Seattle Washington United States 98108
    100 CCOP - Northwest Tacoma Washington United States 98405-0986
    101 Madigan Army Medical Center Tacoma Washington United States 98431-5000

    Sponsors and Collaborators

    • Southwest Oncology Group
    • National Cancer Institute (NCI)

    Investigators

    • Study Chair: Peter J. VanVeldhuizen, MD, Kansas City Veteran Affairs Medical Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00016939
    Other Study ID Numbers:
    • CDR0000068634
    • SWOG-S0109
    First Posted:
    Sep 9, 2003
    Last Update Posted:
    Jun 24, 2013
    Last Verified:
    Jan 1, 2008

    Study Results

    No Results Posted as of Jun 24, 2013